IL5 and asthma: In another study including a small number of patients with difficult-to-treat asthma who were receiving high-dose ICS and/or oral CS, anti-IL-5 was able to reduce blood eosinophils but did not have an effect on other clinical outcomes apart from a small improvement in lung function— forced expiratory volume in the 1st second (FEV1) [94].